Attività di insider trading

Comments

Intellia Therapeutics Attività di insider trading

NTLANASDAQ

Logo offerto da Benzinga Data

Commercio con il pubblico

$14.63

-1.27-7.99%

In chiusura: Jan 23, 4:00 PM EST

$14.55

-0.0764-0.52%

Post-mercato: Jan 23, 7:42 PM EST

Panoramica Notizie Utili Opzioni Valutazioni degli analisti

Insider trading

Vendite allo scoperto Commerci governativi Rapporto azionario

Attività di insider trading

Tieni traccia delle ultime attività di insider trading Intellia Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Intellia Therapeutics.

Cos'è l'attività interna?

L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.

Cosa stanno facendo gli Intellia Therapeutics Inc addetti ai lavori?

A Intellia Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 83.84K azioni del valore di $772.14K, nel frattempo, gli addetti ai lavori hanno ha riferito di aver acquistato un totale di 150.00K azioni per un valore totale di $1.40M.

Notevoli acquisti e vendite recenti di insider

Il giorno gennaio 7, 2026, Fred Cohen, l'azienda - purchased 150K condivisioni per $9.35 ciascuna.
Il giorno gennaio 7, 2026, Michael Dube, l'azienda VP, CHIEF ACCOUNTING OFFICER sold 2.99K condivisioni per $9.21 ciascuna.
Il giorno gennaio 7, 2026, Edward Dulac III, l'azienda EVP, CHIEF FINANCIAL OFFICER sold 6.38K condivisioni per $9.21 ciascuna.

Statistiche sulla proprietà per Intellia Therapeutics Inc

Numero di azioni emesse

115.830M

Azioni possedute dagli insider

3.482M

Percentuale posseduta dagli Insider

3.01%

Azioni possedute dagli investitori istituzionali

68.206M

Percentuale posseduta dagli investitori istituzionali

58.9%


Jan 07, 2026	JOHN LEONARD	PRESIDENT AND CEO	-34.15K	$9.21	-$314.48K	SELL	-3.09%	1.07M	Jan 05	View
Jan 07, 2026	Birgit Schultes	EVP, CHIEF SCIENTIFIC OFFICER	-8.51K	$9.21	-$78.36K	SELL	-7.95%	98.53K	Jan 05	View
Jan 07, 2026	James Basta	EVP, GENERAL COUNSEL	-10.40K	$9.21	-$95.76K	SELL	-9.29%	101.53K	Jan 05	View
Jan 07, 2026	Fred Cohen	—	150.00K	$9.35	$1.40M	BUY	261.08%	207.45K	Jan 05	View
Jan 07, 2026	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	-11.90K	$9.21	-$109.63K	SELL	-8.94%	121.25K	Jan 05	View
Jan 07, 2026	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-9.52K	$9.21	-$87.63K	SELL	-9.85%	87.12K	Jan 05	View
Jan 07, 2026	Edward Dulac III	EVP, CHIEF FINANCIAL OFFICER	-6.38K	$9.21	-$58.75K	SELL	-6.01%	99.68K	Jan 05	View
Jan 07, 2026	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	-2.99K	$9.21	-$27.53K	SELL	-5.41%	52.28K	Jan 05	View
Dec 12, 2025	JOHN LEONARD	PRESIDENT AND CEO	-29.63K	$8.16	-$436.72K	SELL	-2.61%	1.11M	Dec 11 - Dec 12	View
Oct 03, 2025	Birgit Schultes	EVP, CHIEF SCIENTIFIC OFFICER	-31.00	$17.38	-$538.78	SELL	-0.03%	105.18K	Oct 01	View
Oct 03, 2025	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	-1.87K	$17.38	-$32.52K	SELL	-3.27%	55.27K	Oct 01	View
Aug 22, 2025	WILLIAM CHASE	—	100.00K	$10.03	$1.00M	BUY	288.24%	134.69K	Aug 20	View
Jul 25, 2025	Edward Dulac III	EVP, CHIEF FINANCIAL OFFICER	-7.46K	$14.02	-$104.62K	SELL	-6.57%	106.06K	Jul 23	View
Jul 03, 2025	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-1.02K	$9.82	-$10.04K	SELL	-1.06%	95.37K	Jul 01	View
Jul 03, 2025	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	-2.50K	$9.95	-$24.90K	SELL	-4.20%	57.14K	Jul 02	View
Jul 02, 2025	JESSE GOODMAN	—	-3.09K	$9.40	-$29.07K	SELL	-11.27%	24.36K	Jun 30 - Jul 01	View
May 01, 2025	Muna Bhanji	—	-265.00	$8.50	-$2.25K	SELL	-1.36%	19.20K	Apr 29	View
Mar 04, 2025	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	31.32K	$8.99	-$6.10K	GRANT	48.90%	95.37K	Mar 01 - Mar 04	View
Mar 04, 2025	James Basta	EVP, GENERAL COUNSEL	37.43K	$8.99	-$23.12K	GRANT	50.24%	111.92K	Mar 01 - Mar 04	View
Jan 31, 2025	Muna Bhanji	—	-265.00	$9.97	-$2.64K	SELL	-1.34%	19.47K	Jan 29	View
Jan 07, 2025	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	-1.37K	$12.18	-$16.71K	SELL	-2.92%	45.64K	Jan 03	View
Jan 07, 2025	James Basta	EVP, GENERAL COUNSEL	-7.07K	$12.18	-$86.16K	SELL	-8.67%	74.50K	Jan 03	View
Jan 07, 2025	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	-9.56K	$12.18	-$116.40K	SELL	-9.83%	87.67K	Jan 03	View
Jan 07, 2025	Derek Hicks	EVP, CHIEF BUSINESS OFFICER	-6.50K	$12.18	-$79.19K	SELL	-9.80%	59.88K	Jan 03	View
Jan 07, 2025	JOHN LEONARD	PRESIDENT AND CEO	-26.81K	$12.18	-$326.51K	SELL	-2.61%	999.53K	Jan 03	View
Jan 07, 2025	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	-8.97K	$12.18	-$109.21K	SELL	-10.38%	77.39K	Jan 03	View
Jan 06, 2025	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-7.98K	$12.17	-$97.09K	SELL	-11.08%	64.05K	Jan 02 - Jan 03	View
Oct 04, 2024	Michael Dube	VP, CHIEF ACCOUNTING OFFICER	-2.01K	$19.01	-$38.25K	SELL	-4.10%	47.01K	Oct 02	View
Jul 03, 2024	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-405.00	$22.93	-$9.29K	SELL	-0.56%	71.47K	Jul 01	View
Jun 20, 2024	Frank Verwiel	—	-1.50K	$25.00	-$37.63K	SELL	-7.74%	17.95K	Jun 17	View
Mar 05, 2024	James Basta	EVP, GENERAL COUNSEL	30.10K	$32.99	-$75.78K	GRANT	58.47%	81.57K	Mar 01 - Mar 04	View
Mar 05, 2024	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	30.63K	$32.99	-$19.96K	GRANT	74.98%	71.47K	Mar 01 - Mar 04	View
Jan 10, 2024	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	-2.27K	$28.87	-$65.68K	SELL	-4.92%	43.93K	Jan 08	View
Jan 05, 2024	JOHN LEONARD	PRESIDENT AND CEO	-19.22K	$29.46	-$566.31K	SELL	-2.08%	904.90K	Jan 03	View
Jan 05, 2024	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	-5.84K	$29.46	-$172.13K	SELL	-9.70%	54.37K	Jan 03	View
Jan 05, 2024	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	-5.53K	$29.46	-$162.97K	SELL	-10.69%	46.20K	Jan 03	View
Jan 05, 2024	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	-5.37K	$29.46	-$158.05K	SELL	-11.68%	40.59K	Jan 03	View
Jan 05, 2024	Derek Hicks	EVP, CHIEF BUSINESS OFFICER	-3.88K	$29.46	-$114.22K	SELL	-9.49%	36.99K	Jan 03	View
Jan 05, 2024	James Basta	EVP, GENERAL COUNSEL	-3.81K	$29.46	-$112.10K	SELL	-6.88%	51.47K	Jan 03	View
Jan 05, 2024	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-4.61K	$29.50	-$135.95K	SELL	-10.14%	40.84K	Jan 03	View
Nov 02, 2023	Muna Bhanji	DIRECTOR	-265.00	$23.90	-$6.33K	SELL	-2.16%	12.00K	Oct 31	View
Aug 02, 2023	Muna Bhanji	DIRECTOR	-265.00	$42.33	-$11.22K	SELL	-2.12%	12.26K	Jul 31	View
Jul 10, 2023	Muna Bhanji	DIRECTOR	-1.87K	$39.30	-$73.37K	SELL	-12.97%	12.53K	Jul 06	View
Jul 06, 2023	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-360.00	$40.51	-$14.58K	SELL	-0.79%	45.15K	Jul 03	View
Jun 22, 2023	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	0.00	$28.63	-$163.65K	SELL-OPTIONS	0.00%	45.15K	Jun 20	View
Mar 03, 2023	James Basta	EVP, GENERAL COUNSEL	35.72K	$43.88	-$47.74K	GRANT	182.63%	55.28K	Mar 01 - Mar 02	View
Jan 06, 2023	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	-4.84K	$37.82	-$182.98K	SELL	-21.53%	17.63K	Jan 04 - Jan 05	View
Jan 06, 2023	JOHN LEONARD	PRESIDENT AND CEO	-6.67K	$37.21	-$248.30K	SELL	-0.80%	825.24K	Jan 04	View
Jan 06, 2023	Derek Hicks	EVP, CHIEF BUSINESS OFFICER	-1.81K	$37.21	-$67.42K	SELL	-9.48%	17.31K	Jan 04	View
Jan 06, 2023	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	-2.57K	$37.21	-$95.78K	SELL	-9.11%	25.69K	Jan 04	View
Jan 06, 2023	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	-2.43K	$37.21	-$90.31K	SELL	-13.61%	15.40K	Jan 04	View
Jan 06, 2023	Eliana Clark	EVP, CHIEF TECHNICAL OFFICER	-2.03K	$37.65	-$76.36K	SELL	-12.29%	14.47K	Jul 01 - Jan 04	View
Jan 06, 2023	James Basta	EVP, GENERAL COUNSEL	-1.14K	$37.21	-$42.34K	SELL	-5.50%	19.56K	Jan 04	View
Mar 04, 2022	JOHN LEONARD	PRESIDENT AND CEO	46.34K	$112.25	-$279.85K	SELL-OPTIONS	5.96%	824.07K	Jan 01 - Mar 01	View
Mar 03, 2022	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	16.17K	$112.25	-$128.86K	SELL-OPTIONS	656.44%	18.63K	Jan 01 - Mar 01	View
Mar 03, 2022	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	15.95K	$112.24	-$117.96K	SELL-OPTIONS	181.56%	24.74K	Jan 01 - Mar 01	View
Mar 03, 2022	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	14.77K	$112.24	-$113.70K	SELL-OPTIONS	∞	14.77K	Jan 01 - Mar 01	View
Nov 09, 2021	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	0.00	$72.67	-$288.25K	SELL-OPTIONS	0.00%	8.71K	Nov 05	View
Oct 15, 2021	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	0.00	$70.53	-$277.96K	SELL-OPTIONS	0.00%	8.71K	Oct 14	View
Oct 13, 2021	John Crowley	DIRECTOR	0.00	$69.19	-$251.80K	SELL-OPTIONS	0.00%	2.09K	Oct 11	View
Oct 07, 2021	John Crowley	DIRECTOR	0.00	$74.68	-$1.12M	SELL-OPTIONS	0.00%	2.09K	Oct 05	View
Sep 23, 2021	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	0.00	$81.22	-$329.26K	SELL-OPTIONS	0.00%	791.00	Sep 21	View
Sep 09, 2021	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	0.00	$97.35	-$576.41K	SELL-OPTIONS	0.00%	0.00	Sep 07	View
Sep 01, 2021	JOHN LEONARD	PRESIDENT AND CEO	0.00	$88.95	-$17.45M	SELL-OPTIONS	0.00%	777.72K	Aug 30 - Sep 01	View
Sep 01, 2021	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	0.00	$84.42	-$13.66M	SELL-OPTIONS	0.00%	2.39K	Aug 30	View
Sep 01, 2021	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	0.00	$85.33	-$349.01K	SELL-OPTIONS	0.00%	791.00	Aug 30	View
Sep 01, 2021	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	0.00	$89.22	-$4.21M	SELL-OPTIONS	0.00%	0.00	Aug 30 - Aug 31	View
Aug 25, 2021	JOHN LEONARD	PRESIDENT AND CEO	0.00	$82.71	-$3.76M	SELL-OPTIONS	0.00%	777.72K	Aug 23	View
Aug 20, 2021	JOHN LEONARD	PRESIDENT AND CEO	0.00	$82.34	-$3.13M	SELL-OPTIONS	0.00%	777.72K	Aug 19	View
Aug 11, 2021	David Lebwohl	EVP, CHIEF MEDICAL OFFICER	0.00	$88.34	-$363.43K	SELL-OPTIONS	0.00%	791.00	Aug 09	View
Aug 06, 2021	Laura SeppLorenzino	EVP, CHIEF SCIENTIFIC OFFICER	0.00	$75.82	-$3.25M	SELL-OPTIONS	0.00%	2.39K	Aug 04	View
Aug 06, 2021	Glenn Goddard	EVP, CHIEF FINANCIAL OFFICER	0.00	$85.16	-$2.64M	SELL-OPTIONS	0.00%	0.00	Aug 05	View
Jun 29, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-553.38K	$132.73	-$73.45M	SELL	-98.22%	10.00K	Jun 28	View
Jun 15, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-201.72K	$87.04	-$17.56M	SELL	-26.37%	563.38K	Jun 11 - Jun 14	View
Apr 30, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-4.51K	$85.43	-$385.55K	SELL	-0.59%	765.10K	Apr 29	View
Apr 28, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-342.96K	$85.96	-$29.48M	SELL	-30.83%	769.61K	Apr 26 - Apr 28	View
Apr 07, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-800.00	$84.98	-$67.98K	SELL	-0.07%	1.11M	Apr 05	View
Apr 06, 2021	CAROLINE DORSA	DIRECTOR	0.00	$44.29	-$568.40K	SELL-OPTIONS	0.00%	5.41K	Apr 05	View
Apr 02, 2021	JOHN LEONARD	PRESIDENT AND CEO	32.83K	$48.89	-$2.19M	SELL-OPTIONS	4.57%	751.78K	Apr 01	View
Apr 02, 2021	Jose Rivera	EVP, GENERAL COUNSEL	46.55K	$47.49	-$2.95M	SELL-OPTIONS	12.31%	424.60K	Apr 01	View
Mar 01, 2021	FRANCOIS JEAN FORMELA	DIRECTOR	-501.94K	$60.29	-$30.26M	SELL	-31.07%	1.11M	Feb 26	View
Feb 09, 2021	Jose Rivera	EVP, GENERAL COUNSEL	9.51K	$46.65	-$477.48K	SELL-OPTIONS	2.57%	380.13K	Feb 09	View
Feb 09, 2021	JOHN LEONARD	PRESIDENT AND CEO	45.73K	$40.62	-$2.73M	SELL-OPTIONS	6.79%	718.95K	Feb 05 - Feb 09	View
Feb 03, 2021	JOHN LEONARD	PRESIDENT AND CEO	139.31K	$41.21	-$7.15M	SELL-OPTIONS	26.09%	673.22K	Feb 01 - Feb 03	View
Feb 03, 2021	Jose Rivera	EVP, GENERAL COUNSEL	54.34K	$36.84	-$2.44M	SELL-OPTIONS	17.18%	370.62K	Feb 01	View
Jan 05, 2021	JOHN LEONARD	PRESIDENT AND CEO	8.14K	$55.86	-$348.51K	SELL-OPTIONS	1.55%	533.90K	Dec 31 - Jan 05	View
Jan 05, 2021	ANDREW SCHIERMEIER	EVP, CHIEF OPERATING OFFICER	3.42K	$55.86	-$76.92K	SELL-OPTIONS	25.79%	16.66K	Dec 31 - Jan 05	View
Jan 05, 2021	Jose Rivera	EVP, GENERAL COUNSEL	2.71K	$55.86	-$116.08K	SELL-OPTIONS	0.87%	314.20K	Dec 31 - Jan 05	View
Dec 18, 2020	PERRY KARSEN	—	0.00	$36.00	-$3.12M	OPTION EXERCISE	0.00%	5.00K	Dec 17	View
Dec 03, 2020	Jose Rivera	—	1.64K	$26.04	-$59.13K	OPTION EXERCISE	0.53%	310.92K	Dec 01	View
Nov 27, 2020	JOHN LEONARD	—	0.00	$27.37	-$783.90K	OPTION EXERCISE	0.00%	525.77K	Nov 27	View
Nov 25, 2020	JOHN LEONARD	—	0.00	$21.41	-$1.46M	OPTION EXERCISE	0.00%	525.77K	Nov 25	View
Nov 18, 2020	JOHN LEONARD	—	0.00	$24.29	-$388.40K	OPTION EXERCISE	0.00%	525.77K	Nov 16	View
Nov 18, 2020	Jose Rivera	—	4.76K	$21.30	-$134.47K	OPTION EXERCISE	1.56%	309.28K	Nov 16 - Nov 18	View
Nov 06, 2020	Jose Rivera	—	1.64K	$20.94	-$24.79K	OPTION EXERCISE	0.54%	304.52K	Nov 04	View
Nov 06, 2020	JOHN LEONARD	—	0.00	$16.41	-$958.50K	OPTION EXERCISE	0.00%	525.77K	Nov 04	View
Oct 16, 2020	Jose Rivera	—	4.38K	$15.52	-$67.58K	OPTION EXERCISE	1.47%	302.89K	Oct 15	View
Oct 09, 2020	JOHN LEONARD	—	0.00	$14.33	-$75.00K	OPTION EXERCISE	0.00%	525.77K	Oct 07	View
Sep 17, 2020	Jose Rivera	—	4.38K	$13.93	-$49.84K	OPTION EXERCISE	1.49%	298.50K	Sep 15	View
Sep 03, 2020	JOHN LEONARD	—	0.00	$14.33	-$75.00K	OPTION EXERCISE	0.00%	525.77K	Sep 01	View
Aug 20, 2020	Jose Rivera	EVP, GENERAL COUNSEL	4.38K	$13.91	-$49.62K	SELL-OPTIONS	1.51%	294.12K	Aug 18	View
Aug 07, 2020	JOHN LEONARD	—	0.00	$14.33	-$75.00K	OPTION EXERCISE	0.00%	525.77K	Aug 06	View
Jul 17, 2020	Jose Rivera	—	4.38K	$14.77	-$59.16K	OPTION EXERCISE	1.54%	289.73K	Jul 15	View
Jul 02, 2020	JOHN LEONARD	—	0.00	$14.33	-$75.00K	OPTION EXERCISE	0.00%	525.77K	Jul 01	View
Jun 18, 2020	Jose Rivera	—	4.38K	$13.91	-$49.62K	OPTION EXERCISE	1.57%	284.49K	Jun 16	View
Jun 05, 2020	JOHN LEONARD	—	0.00	$14.33	-$75.00K	OPTION EXERCISE	0.00%	525.77K	Jun 03	View
May 28, 2020	Jose Rivera	—	4.38K	$14.02	-$50.79K	OPTION EXERCISE	1.59%	280.11K	May 26	View
Mar 12, 2019	ANDREW SCHIERMEIER	EVP, DEV AND CORP STRATEGY	7.50K	$15.72	$117.88K	BUY	86.77%	16.14K	Mar 06	View
Jul 18, 2018	FRANCOIS JEAN FORMELA	DIRECTOR	-6.69K	$31.17	-$208.40K	SELL	-0.41%	1.62M	Jul 16	View
Jun 20, 2018	FRANCOIS JEAN FORMELA	DIRECTOR	-6.69K	$27.96	-$186.91K	SELL	-0.36%	1.84M	Jun 19	View
May 17, 2018	FRANCOIS JEAN FORMELA	DIRECTOR	-6.69K	$25.04	-$167.39K	SELL	-0.32%	2.06M	May 16	View
May 15, 2018	JOHN LEONARD	PRESIDENT AND CEO	-8.40K	$24.00	-$201.60K	SELL	-12.57%	58.41K	May 14	View
Mar 22, 2018	FRANCOIS JEAN FORMELA	DIRECTOR	-39.24K	$23.87	-$936.74K	SELL	-1.69%	2.28M	Mar 20	View
Jan 30, 2018	Caribou Biosciences Inc	—	-550.64K	$26.78	-$14.75M	SELL	-12.12%	3.99M	Jan 29	View
Dec 14, 2017	Novartis Institutes for BioMedical Research Inc AG NOVARTIS	10% OWNER	-1.52M	$18.30	-$27.87M	SELL	-26.94%	4.13M	Dec 12	View
Dec 08, 2017	Nessan Bermingham	PRESIDENT & CEO	-336.78K	$20.78	-$7.00M	SELL	-42.36%	458.25K	Dec 06 - Dec 08	View
Sep 13, 2017	Caribou Biosciences Inc	—	-1.05M	$0.00	$0.00	SELL	-18.75%	4.54M	Sep 13	View
Jul 11, 2017	FRANCOIS JEAN FORMELA	DIRECTOR	-150.00K	$16.24	-$2.44M	SELL	-4.02%	3.58M	Jul 07 - Jul 11	View
Jul 11, 2017	Atlas Venture Fund IX LP Atlas Venture Associates IX LP Atlas Venture Associates IX LLC	10% OWNER	-150.00K	$16.24	-$2.44M	SELL	-4.02%	3.58M	Jul 07 - Jul 11	View
Mar 13, 2017	Atlas Venture Associates IX LP Atlas Venture Associates IX LLC	10% OWNER	-21.13K	$13.91	-$293.84K	SELL	-0.56%	3.73M	Mar 09 - Mar 10	View
Mar 13, 2017	FRANCOIS JEAN FORMELA	DIRECTOR	-21.13K	$13.91	-$293.84K	SELL	-0.56%	3.73M	Mar 09 - Mar 10	View
May 13, 2016	ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Global Healthcare GP LLC Samuel D Isaly	DIRECTOR	2.66M	$18.00	$4.50M	BUY	∞	2.66M	May 11	View
May 13, 2016	Temasek Holdings Private Ltd Fullerton Management Pte Ltd Temasek Life Sciences Private Ltd TLS Beta Pte Ltd	10% OWNER	790.53K	$18.00	$5.40M	BUY	∞	790.53K	May 11	View
May 11, 2016	Novartis Institutes for BioMedical Research Inc AG NOVARTIS	10% OWNER	5.57M	$18.00	$5.00M	BUY	∞	5.57M	May 11	View
May 11, 2016	CARL GORDON	DIRECTOR	2.66M	$18.00	$4.50M	BUY	∞	2.66M	May 11	View
May 11, 2016	BAKER BROS ADVISORS LP FELIX BAKER JULIAN BAKER Baker Bros Advisors GP LLC	—	1.06M	$18.00	$3.60M	BUY	∞	976.21K	May 11	View

FAQ

L'insider trading è legale?

L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.

Quali sono alcuni esempi di manipolazione del mercato?

L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.

Sfoglia insider trading su tutte le azioni.